Michael K Gibson, MD, PhD, FACP, is Co-Leader of the Esophageal Cancer Program and Assistant Professor of Medicine and Cardiothoracic Surgery at the University of Pittsburgh Cancer Institute (UPCI). His research focuses on translating novel therapeutics for treatment of upper gastrointestinal (UGI) cancers. To forward this effort, he leads the multidisciplinary UGI clinical trials program at the UPCI and co-leads the translational laboratory effort in esophageal cancer. Dr Gibson is Principal Investigator on multiple clinical trials supported by industry, investigator-initiated mechanisms and the National Cancer Institute (NCI) cooperative groups. He is a member of the NCI Esophago-Gastric Task Force, the Eastern Cooperative Oncology Group Gastrointestinal Committee, and the NCI Central Institutional Review Board. Dr Gibson has authored articles in multiple journals, including the Journal of Clinical Oncology and Clinical Cancer Research. He has presented his research at numerous meetings, including those of the American Society of Clinical Oncology, the World Organization for Specialized Studies on Diseases of the Esophagus, and the Japan Esophageal Society.